Complement C3 Test

Complement C3 is one of the most important proteins in the immune system’s complement pathway—a set of molecular tools that help the body fight off infections, clear damaged cells, and trigger inflammation when needed. C3 sits at the crossroads of all three complement activation pathways (classical, lectin, and alternative) and plays a key role in tagging harmful microbes and debris for destruction. Once activated, it breaks into two parts: C3a, which signals inflammation, and C3b, which binds to targets like bacteria and marks them for removal.

Because of its central role, C3 also has wide-reaching effects on many conditions, including autoimmune diseases, infections, cardiovascular and metabolic health, and rare blood disorders.

Implications for Autoimmune Diseases

C3 levels are often used to monitor activity in autoimmune conditions like systemic lupus erythematosus (SLE). During disease flares—especially those involving the kidneys (lupus nephritis)—C3 is often consumed in the immune response, leading to lower levels in blood tests. In pregnant women with lupus, drops in C3 during the first trimester have been linked to an increased risk of flares and adverse outcomes. As a result, clinicians use C3 levels as part of disease monitoring and to help guide treatment decisions.

Impact on Metabolic and Cardiovascular Health

Complement C3 is also linked to chronic inflammation seen in obesity and metabolic syndrome. Elevated levels of C3 are associated with insulin resistance and may serve as an early signal of diabetes risk.

Similarly, C3 may contribute to cardiovascular disease in individuals undergoing hemodialysis. In these patients, high baseline C3 levels have been linked to a greater risk of heart attacks and strokes—suggesting that chronic inflammation driven by C3 could be a hidden driver of vascular damage.

Role in Nonalcoholic Fatty Liver Disease (NAFLD)

Several studies have shown that high C3 levels correlate with both the risk and severity of NAFLD, a condition where fat accumulates in the liver without alcohol use. This may be because C3 amplifies inflammatory responses and contributes to metabolic dysregulation. Some researchers are now exploring whether C3 could be used as a biomarker to help diagnose or monitor progression of fatty liver disease.

Implications for Infectious Diseases

Infections like COVID-19 also affect complement activation. Lower C3 levels in hospitalized patients with COVID-19 have been associated with worse outcomes, including higher rates of severe disease and mortality. This pattern likely reflects intense immune system activation and C3 consumption, which may make C3 a useful biomarker in guiding treatment.

Role in Rare Blood Disorders

C3 is also involved in rare disorders such as paroxysmal nocturnal hemoglobinuria (PNH), a disease where red blood cells are attacked by the immune system. In PNH, unchecked complement activity—including C3-mediated destruction—leads to anemia and other serious complications. New therapies that block C3 activation (such as pegcetacoplan) have shown promise in reducing symptoms and improving quality of life for people with PNH.

Implications for Longevity

C3’s involvement in inflammation, immune surveillance, and cellular cleanup makes it a powerful indicator of long-term health. Chronically elevated C3 may reflect low-grade inflammation that increases the risk of cardiovascular disease, fatty liver, diabetes, and even some neurodegenerative diseases. Conversely, too little C3—often due to genetic conditions or overconsumption during autoimmunity—can leave the body vulnerable to infections and uncontrolled immune responses.

Tracking C3 over time offers insight into the immune system’s balance between defense and overreaction. In this way, C3 is more than a snapshot of inflammation—it’s a window into how well the immune system is managing the delicate dance between attacking threats and preserving self.